{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:28:35Z","timestamp":1761488915783},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1212\/wnl.51.5.1433","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:36:49Z","timestamp":1336916209000},"page":"1433-1439","source":"Crossref","is-referenced-by-count":26,"title":["Contemporary opinions about Mary Walker"],"prefix":"10.1212","volume":"51","author":[{"given":"John C.","family":"Keesey","sequence":"first","affiliation":[{"name":"From the Department of Neurology, University of California Los Angeles, School of Medicine, Los Angeles, CA. Winner of the 1998 Lawrence C. McHenry Award for the History of Neurology, presented at the 50th annual meeting of the American Academy of Neurology, Minneapolis, MN, April 28, 1998."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"1","volume":"1","year":"1934","unstructured":"Walker MB. Treatment of myasthenia gravis with physostigmine. Lancet 1934;1:1200-1201.","journal-title":"Lancet"},{"key":"e_1_3_1_3_2","first-page":"1","volume":"2","year":"1974","unstructured":"PWR. Dr Mary Walker. Lancet 1974;2:1582. Obituary.","journal-title":"Lancet"},{"key":"e_1_3_1_4_2","first-page":"3","volume":"81","year":"1934","unstructured":"Dale HH, Feldberg W. Chemical transmission at motor nerve endings in voluntary muscle? J Physiol (London) 1934;81:39P-40P.","journal-title":"Chemical transmission at motor nerve endings in voluntary muscle? J Physiol (London)"},{"key":"e_1_3_1_5_2","first-page":"7","volume":"1","year":"1935","unstructured":"Denny-Brown D. Physostigmine and belladonna by mouth in myasthenia. Lancet 1935;1:767.","journal-title":"Lancet"},{"key":"e_1_3_1_6_2","first-page":"4","volume":"43","year":"1931","unstructured":"Aeschlimann JA, Reinert M. The pharmacological action of some analogues of physostigmine. J Pharm Exper Therap 1931;43:413-444.","journal-title":"J Pharm Exper Therap"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1017\/S002572730003009X"},{"key":"e_1_3_1_8_2","first-page":"7","volume":"28","year":"1935","unstructured":"Walker MB. Case showing the effect of Prostigmin on myasthenia gravis. Proc R Soc Med 1935;28:759-761.","journal-title":"Proc R Soc Med"},{"key":"e_1_3_1_9_2","first-page":"1","volume":"68","year":"1971","unstructured":"Laurent LPE. Prostigmin and myasthenia gravis: some reminiscences of Mary Walker's discovery. Charing Cross Hosp Gaz 1971;68:116-118.","journal-title":"Charing Cross Hosp Gaz"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"McAlpine D. Treatment of myasthemia gravis with \"Prostigmin.\" Lancet 1935;1:516.","DOI":"10.1016\/S0140-6736(01)00762-0"},{"key":"e_1_3_1_11_2","first-page":"4","volume":"1","year":"1935","unstructured":"Laurent LPE. Clinical observations on the use of Prostigmin in the treatment of myasthenia gravis. Br Med J 1935;1:463-465.","journal-title":"Br Med J"},{"key":"e_1_3_1_12_2","first-page":"4","volume":"1","year":"1935","unstructured":"Pritchard EAB. The use of \"Prostigmin\" in the treatment of myasthenia gravis. Lancet 1935;1:432-435.","journal-title":"Lancet"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1970.00480250005001"},{"key":"e_1_3_1_14_2","first-page":"6","volume":"100","year":"1944","unstructured":"Viets HR. Clinical aspects of myasthemia gravis. J Nerv Ment Dis 1944;100:613-615.","journal-title":"J Nerv Ment Dis"},{"key":"e_1_3_1_15_2","first-page":"3","volume":"84","year":"1935","unstructured":"Pritchard EAB, Walker MB. The effect of prostigmin on the symptoms and on the myogram in myasthenia gravis, J Physiol (Lond) 1935;84:35P-36P.","journal-title":"The effect of prostigmin on the symptoms and on the myogram in myasthenia gravis, J Physiol (Lond)"},{"key":"e_1_3_1_16_2","first-page":"4","volume":"2","year":"1935","unstructured":"Walker MB. Potassium chloride in myasthenia gravis. Lancet 1935;2:47.","journal-title":"Lancet"},{"key":"e_1_3_1_17_2","first-page":"1","volume":"1","year":"1935","unstructured":"Laurent LPE, Walther WW. The influence of large doses of potassium chloride on myasthenia gravis. Lancet 1935;1:1434-1435.","journal-title":"Lancet"},{"key":"e_1_3_1_18_2","first-page":"4","volume":"3","year":"1937","unstructured":"Aitken RS, Allott EN, Gastelden LIM, Walker M. Observations on a case of familial period analysis. Clin Sci 1937;3:47-57.","journal-title":"Clin Sci"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Keeney AH Keeney VT. Mary B. Walker MD and the pioneering use of prostigmin to treat myasthenia gravis. Doc Ophthalmol 1997;125-134.","DOI":"10.1007\/BF02569052"},{"key":"e_1_3_1_20_2","first-page":"1","volume":"1","year":"1936","unstructured":"Laurent LPE, Walker MB. Oral and parenteral administration of Prostigmin and its analogues in myasthenia gravis. Lancet 1936;1:1457-1459.","journal-title":"Lancet"},{"key":"e_1_3_1_21_2","first-page":"1","volume":"2","year":"1974","unstructured":"KSM. Mary Broadfoot Walker. Lancet 1974;2:1401-1402. Obituary.","journal-title":"Lancet"},{"key":"e_1_3_1_22_2","first-page":"7","volume":"31","year":"1938","unstructured":"Walker MB. Myasthenia gravis: a case in which fatigue of the forearm muscles could induce paralysis of the extra-ocular muscles. Proc R Soc Med 1938;31:722.","journal-title":"Proc R Soc Med"},{"key":"e_1_3_1_23_2","first-page":"4","volume":"1","year":"1973","unstructured":"Walker MB. Some discoveries on myasthenia gravis. Br Med J 1973;1:42-43.","journal-title":"Br Med J"},{"key":"e_1_3_1_24_2","first-page":"4","volume":"82","year":"1975","unstructured":"Patten BM. An hypothesis to account for the Mary Walker phenomenon. Ann Intern Med 1975;82:411-415.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_25_2","first-page":"4","volume":"55","year":"1962","unstructured":"Ferguson FR. President's address: a critical review of the clinical features of myasthenia gravis. Proc R Soc Med 1962;55:49-52.","journal-title":"Proc R Soc Med"},{"key":"e_1_3_1_26_2","unstructured":"Works R. Why are the called \"Viets\" fellowships? MG Newsletter Wisconsin Chapter of the Myasthenia Gravis Foundation April 1987:1-5."},{"key":"e_1_3_1_27_2","first-page":"1","volume":"31","year":"1895","unstructured":"Jolly F. Ueber myasthenia gravis pseudoparalytica. Berliner Klinische Wochenschrift 1895;31:1-7.","journal-title":"Berliner Klinische Wochenschrift"},{"key":"e_1_3_1_28_2","first-page":"6","volume":"25","year":"1896","unstructured":"Murri A. Sur un cas de maladie d'Erb. Arch Ital biol 1896;25:64-92.","journal-title":"Arch Ital biol"},{"key":"e_1_3_1_29_2","first-page":"6","volume":"128","year":"1932","unstructured":"Remen L. Zur pathogenese und therapie der myasthenia gravis pseudoparalytica. Deutsche Z Nervenheilkunde 1932;128:66-78.","journal-title":"Deutsche Z Nervenheilkunde"},{"key":"e_1_3_1_30_2","first-page":"1","volume":"6","year":"1914","unstructured":"Darwin F. First Galton lecture. Eugenics Rev 1914;6:1.","journal-title":"Eugenics Rev"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.5.1433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T16:15:22Z","timestamp":1711556122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.5.1433"}},"subtitle":["A shy pioneer of therapeutic neurology"],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1212\/WNL.51.5.1433"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.5.1433","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}